IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-01-09 (newstrail.com)
Social Intelligence Market to Accelerate Growth with Salesforce, IQVIA, Hootsuite -
The latest study released on the Global Social Intelligence Market by HTF MI Research evaluates market size, trend, and forecast to 2030. The Social
Read more
2024-12-23 (pharmacyscanner.it)
Iqvia, closing of the year in break-even for the pharmacy which grows in 2023 only due to prices |
Last report of the year for the pharmacy market which - says Iqvia - is starting to close 2024 without
Read more
2024-11-06 (revuepharma.fr)
The painkillers match
Focus on the analgesics market by IQVIA France.
Read more
2024-09-26 (imfarmacias.es)
The pharmaceutical market resists despite the reduction in average spending per inhabitant
Between 2022 and 2023, as shown by the data provided by the firm IQVIA, there was an average per capita reduction in spending on community pharmacies not so much due to inflation, which was somewhat lower, but due to changes observed in the behavior of the patient-consumer...
Read more
2024-09-20 (isbzdrowie.pl)
The e-pharmacy market is growing
In 2023, the sales value on the Polish e-pharmacy market reached PLN 1,892 million (at retail prices) and was PLN 291 million higher than in 2022.
Read more
2024-09-19 (termedia.pl)
Increase in sales in online pharmacies
The sales value on the Polish e-pharmacy market in 2023 reached value of PLN 1.892 billion (at retail prices) and was PLN 291 million higher than in 2022. Moreover, 333 stationary pharmacies reported their intention to operate mail order sales of medicines - we read in the latest IQVIA report.
Read more
2024-09-12 (theexchange.africa)
Africa pharmaceutical independence, is the world ready?
Africa pharmaceutical investment is well underway as the continent seeks to produce drugs loacally; how will this impact the global industry?
Read more
2024-02-27 (chemistanddruggist.co.uk)
Long-awaited NHSE pharmacy economic review to begin in March
A healthcare data company and consultancy will jointly run the NHSE-commissioned economic review of the pharmacy sector, it has been revealed.
Read more
2024-02-22 (endpts.com)
Clinical trial starts slowed to below pre-pandemic levels last year, IQVIA analysis finds
Biopharma R&D spending rebounded in 2023, up $11 billion from 2022 following a steep post-pandemic decline. But the number of new clinical trial starts slowed to levels from before the Covid-19 pandemic, the data and services firm IQVIA said in a new report.
Read more
2024-02-14 (reuters.com)
IQVIA quarterly results beat estimates on strong demand for research services
IQVIA Holdings beat Wall Street estimates for fourth-quarter sales and profit on Wednesday, on the back of strong demand for its drug research and development services.
Read more
2024-02-05 (pressetext.com)
Growth of the drug market significantly slowed by price cuts
In 2023, the Swiss medicines market had a turnover of 7.4 billion francs, or +4.9% (at factory prices). Although demand for medicines increased, price reductions reduced growth by 2.7%.
Read more
2024-02-01 (managedhealthcareexecutive.com)
CMS Begins Medicare Drug Price Negotiations
New research finds that in 2022, U.S. prices across all drugs were almost three times higher than in other countries.
Read more